Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−2030

Abstract

The economic burden of lung cancer in China in 2017 is substantial and more likely to increase significantly in the future. Policy makers need to take urgent actions in budget making for health systems. The economic burden could be alleviated by reducing the disease burden of lung cancer via effective control and prevention actions.